Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma
2007 ◽
Vol 13
(6)
◽
pp. 1801-1809
◽
Keyword(s):
Phase I
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4754-4754
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 2590-2590
◽